Drug intelligence / Profile preview

sinensetin

Development stage
Preclinical
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Sinensetin is a plant-derived polymethoxylated flavonoid (specifically an O-methylated flavone) found in Orthosiphon aristatus (also known as Orthosiphon stamineus or "cat's whiskers") and in the peels of various citrus fruits such as sweet orange. It has demonstrated a broad range of pharmacological activities in vitro and in vivo including strong anticancer effects as well as anti-inflammatory, antioxidant, antimicrobial (including antifungal), anti-obesity (by enhancing adipogenesis and lipolysis), anti-dementia/neuroprotective effects and vasorelaxant properties. Mechanistically it is reported to exert its actions through inhibition of angiogenesis and inflammation pathways; it also induces cell differentiation and inhibits linoleic acid oxidation. Sinensetin shows promising potency with minimal toxicity but remains primarily a research compound; further studies are needed to clarify its mechanisms of action and clinical potential[1][2][3][4][5][6].

Other names
3',4',5,6,7-pentamethoxyflavonepedalitin permethyl ether2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxychromen-4-one6-hydroxyluteolin 5,6,7,3',4'-pentamethyl ether
02

Targets

VEGFR2 (Vascular endothelial growth factor receptor 2)MAP2K6 (MEK6)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)ABCG2 (ATP-binding cassette sub-family G member 2)ABCB1 (P-glycoprotein)EGFR T790M (Epidermal growth factor receptor T790M mutant)

Beyond the preview

Go deeper on sinensetin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sinensetin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call